Intervention not reported
rhIGF‐I, 0.1 mg/kg/day ‐ change in AALSRS at 9 months · patients with amyotrophic lateral sclerosis/motor neuron disease
1 finding from 1 review
- Recombinant human insulin‐like growth factor I (rhIGF‐I) for the treatment of amyotrophic lateral sclerosis/motor… 2012 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 357 participantsLow